Immediate Impact
2 from Science/Nature 56 standout
Citing Papers
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
Steatotic liver disease
2024 Standout
Works of Hideki Suganami being referenced
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease
2021
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hideki Suganami | 890 | 926 | 721 | 80 | 2.1k | |
| Tova Chajek‐Shaul | 718 | 778 | 711 | 70 | 2.4k | |
| Pi‐Jung Hsiao | 553 | 583 | 643 | 84 | 2.1k | |
| Ross W. Milne | 1237 | 916 | 927 | 69 | 3.1k | |
| Hideaki Jinnouchi | 752 | 1044 | 538 | 81 | 2.3k | |
| Haibing Chen | 692 | 335 | 210 | 91 | 1.8k | |
| Markku O. Pentikäinen | 822 | 395 | 796 | 62 | 2.9k | |
| Pascale Benlian | 540 | 492 | 762 | 85 | 2.1k | |
| N Yamada | 892 | 1081 | 921 | 73 | 3.1k | |
| Venkatesan Radha | 728 | 817 | 543 | 102 | 2.3k | |
| Pamela W. Anderson | 518 | 1100 | 252 | 40 | 2.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...